abstract |
The present invention provides a method for generating human immature dental pulp stem cells (hIDPSC) that express CD44 and CD13 and lack expression of CD146. The present invention also includes Parkinson's disease (PD), multiple sclerosis, amyotrophic lateral sclerosis (ALS), stroke, autoimmune encephalomyelitis, diabetic neuropathy, glaucomatous neuropathy, Alzheimer's disease, Huntington Provided is a composition for use in the treatment of a neurological disease or condition selected from the group consisting of disease (HD), autism, schizophrenia, stroke, ischemia, movement disorders, and convulsive disorders . [Selection figure] None |